Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.
Anderson WJ, Doyle LA. Updates from the 2020 World Health Organization classification of soft tissue and bone tumours. Histopathology. 2021;78(5):644–57. https://doi.org/10.1111/his.14265.
Folpe AL. ‘I Can’t Keep Up!’: an update on advances in soft tissue pathology occurring after the publication of the 2020 World Health Organization classification of soft tissue and bone tumours. Histopathology. 2022;80(1):54–75. https://doi.org/10.1111/his.14460.
Blay JY, Soibinet P, Penel N, Bompas E, Duffaud F, Stoeckle E, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28(11):2852–9. https://doi.org/10.1093/annonc/mdx484.
Article PubMed PubMed Central Google Scholar
Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–81. https://doi.org/10.1002/cncr.23592.
Rybak LD. Fire and ice: thermal ablation of musculoskeletal tumors. Radiol Clin North Am. 2009;47(3):455–69. https://doi.org/10.1016/j.rcl.2008.12.006.
Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):S187–91. https://doi.org/10.1016/j.jvir.2009.12.403.
Article PubMed PubMed Central Google Scholar
Parvinian A, Kurup AN, Atwell TD, Schmit GD, Schmitz JJ, Morris JM. Percutaneous cryoablation of large tumors: safety, feasibility, and technical considerations. Cardiovasc Intervent Radiol. 2022;45(1):69–79. https://doi.org/10.1007/s00270-021-03025-7.
Parvinian A, Morris JM, Johnson-Tesch BA, Kurup AN. Thermoprotection of neural structures during musculoskeletal ablation. Cardiovasc Intervent Radiol. 2023;46(11):1495–503. https://doi.org/10.1007/s00270-023-03407-z.
Kurup AN, Schmit GD, Morris JM, Atwell TD, Schmitz JJ, Weisbrod AJ, et al. Avoiding complications in bone and soft tissue ablation. Cardiovasc Intervent Radiol. 2017;40(2):166–76. https://doi.org/10.1007/s00270-016-1487-y.
Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, et al. Kidney cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(1):71–90. https://doi.org/10.6004/jnccn.2022.0001.
Article CAS PubMed PubMed Central Google Scholar
Colak C, Hull C, Simpfendorfer C, Ilaslan H, Forney M. Extra-abdominal desmoid fibromatosis: cryoablation versus traditional therapies. Clin Imaging. 2022;88:9–16. https://doi.org/10.1016/j.clinimag.2022.05.001.
Schmitz JJ, Schmit GD, Atwell TD, Callstrom MR, Kurup AN, Weisbrod AJ, et al. Percutaneous cryoablation of extraabdominal desmoid tumors: a 10-year experience. AJR Am J Roentgenol. 2016;207(1):190–5. https://doi.org/10.2214/AJR.15.14391.
Redifer Tremblay K, Lea WB, Neilson JC, King DM, Tutton SM. Percutaneous cryoablation for the treatment of extra-abdominal desmoid tumors. J Surg Oncol. 2019;120(3):366–75. https://doi.org/10.1002/jso.25597.
Article PubMed PubMed Central Google Scholar
Kasper B, Baumgarten C, Garcia J, Bonvalot S, Haas R, Haller F, et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol. 2017;28(10):2399–408. https://doi.org/10.1093/annonc/mdx323.
Article CAS PubMed PubMed Central Google Scholar
Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Pechoux C, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009;16(9):2587–93. https://doi.org/10.1245/s10434-009-0586-2.
van Houdt WJ, Husson O, Patel A, Jones RL, Smith MJF, Miah AB, et al. Outcome of primary desmoid tumors at all anatomic locations initially managed with active surveillance. Ann Surg Oncol. 2019;26(13):4699–706. https://doi.org/10.1245/s10434-019-07826-6.
Huang K, Hong R, Luo L, Zhao H, Wang Y, Li Y, et al. Efficacy and safety of different thermal ablative therapies for desmoid-type fibromatosis: a systematic review and meta-analysis. Quant Imaging Med Surg. 2023;13(10):6683–97. https://doi.org/10.21037/qims-23-289.
Article PubMed PubMed Central Google Scholar
•• Kurtz JE, Buy X, Deschamps F, Sauleau E, Bouhamama A, Toulmonde M, et al. CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. Eur J Cancer. 2021;143:78–87. https://doi.org/10.1016/j.ejca.2020.10.035. Prospective multicenter nonrandomized study demonstrating feasibility of cryoablation for treatment of progressing non-abdominopelvic desmoid fibromatosis. A follow-up prospective randomized study, CRYODESMO-02, is currently ongoing.
Article CAS PubMed Google Scholar
von Mehren M, Kane JM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, et al. Soft tissue sarcoma, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(7):815–33. https://doi.org/10.6004/jnccn.2022.0035.
Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(✩). Ann Oncol. 2021;32(11):1348–65. https://doi.org/10.1016/j.annonc.2021.07.006.
Article CAS PubMed Google Scholar
Stojadinovic A, Karpoff HM, Antonescu CR, Shah JP, Singh B, Spiro RH, et al. Dermatofibrosarcoma protuberans of the head and neck. Ann Surg Oncol. 2000;7(9):696–704. https://doi.org/10.1007/s10434-000-0696-3.
Article CAS PubMed Google Scholar
Xu J, Li J, Zhou X, Zeng J, Yao F, Wang Y, et al. Cryotherapy for local recurrent dermatofibrosarcoma protuberans: experience in 19 patients. Cryobiology. 2014;68(1):134–8. https://doi.org/10.1016/j.cryobiol.2014.01.009.
Fan W, Niu L, Wang Y, Zhang Y, Yao X, Tan G, et al. Percutaneous computed tomography-guided cryoablation for recurrent retroperitoneal soft tissue sarcoma: a study of safety and efficacy. Oncotarget. 2016;7(27):42639–49. https://doi.org/10.18632/oncotarget.9476.
Article PubMed PubMed Central Google Scholar
Fan WZ, Niu LZ, Wang Y, Yao XH, Zhang YQ, Tan GS, et al. Initial experience: alleviation of pain with percutaneous CT-guided cryoablation for recurrent retroperitoneal soft-tissue sarcoma. J Vasc Interv Radiol. 2016;27(12):1798–805. https://doi.org/10.1016/j.jvir.2016.06.034.
Yu W, Tang L, Lin F, Jiang L, Shen Z. Significance of HIFU in local unresectable recurrence of soft tissue sarcoma, a single-center, respective, case series in China. Surg Oncol. 2019;30:117–21. https://doi.org/10.1016/j.suronc.2019.06.004.
Deschamps F, Farouil G, Ternes N, Gaudin A, Hakime A, Tselikas L, et al. Thermal ablation techniques: a curative treatment of bone metastases in selected patients? Eur Radiol. 2014;24(8):1971–80. https://doi.org/10.1007/s00330-014-3202-1.
Article CAS PubMed Google Scholar
Lessard AM, Gilchrist J, Schaefer L, Dupuy DE. Palliation of recurrent Ewing sarcoma of the pelvis with cryoablation and somatosensory-evoked potentials. J Pediatr Hematol Oncol. 2009;31(1):18–21. https://doi.org/10.1097/MPH.0b013e31818ab2b7.
Li J, Guo Z, Yang Q, Ji C, Wang Z. Adjuvant argon-based cryoablation for joint-preserving tumor resection in patients with juxta-articular osteosarcoma around the knee. Cryobiology. 2015;71(2):236–43. https://doi.org/10.1016/j.cryobiol.2015.07.005.
Li J, Guo Z, Wang Z, Fan H, Fu J. Does microwave ablation of the tumor edge allow for joint-sparing surgery in patients with osteosarcoma of the proximal tibia? Clin Orthop Relat Res. 2015;473(10):3204–11. https://doi.org/10.1007/s11999-015-4447-y.
Article PubMed PubMed Central Google Scholar
Yamakado K, Matsumine A, Nakamura T, Nakatsuka A, Takaki H, Matsubara T, et al. Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates. Int J Clin Oncol. 2014;19(5):955–62. https://doi.org/10.1007/s10147-013-0640-8.
Fan QY, Zhou Y, Zhang M, Ma B, Yang T, Long H, et al. Microwave ablation of primary malignant pelvic bone tumors. Front Surg. 2019;6:5. https://doi.org/10.3389/fsurg.2019.00005.
Article PubMed PubMed Central Google Scholar
Li C, Zhang W, Fan W, Huang J, Zhang F, Wu P. Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound. Cancer. 2010;116(16):3934–42. https://doi.org/10.1002/cncr.25192.
Chen W, Zhu H, Zhang L, Li K, Su H, Jin C, et al. Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation. Radiology. 2010;255(3):967–78. https://doi.org/10.1148/radiol.10090374.
Yu W, Tang L, Lin F, Yao Y, Shen Z, Zhou X. High-intensity focused ultrasound: noninvasive treatment for local unresectable recurrence of osteosarcoma. Surg Oncol. 2015;24(1):9–15. https://doi.org/10.1016/j.suronc.2014.10.001.
Comments (0)